BUD vs PM

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of just 2/9, indicating significant operational and profitability concerns. Despite this, the stock trades above its Graham Number of $52.90 at $69.88, supported by a bullish analyst recommendation and strong recent price performance. Earnings growth has collapsed year-over-year (-48.6%), yet the company consistently beats estimates, showing some earnings quality. Profit margins and cash flow generation remain solid, but missing key financial health metrics like ROE, ROA, and Altman Z-Score limits confidence in stability. The dividend is sustainable with a 37.5% payout ratio, but insider sentiment and technical trend are weak.

Philip Morris International (PM) presents a compelling investment case supported by strong profitability, consistent earnings growth, and a resilient dividend profile. Despite near-term price weakness over the past six months (-7.3%), the stock has delivered exceptional long-term returns (+153.1% over 5Y), underpinned by robust YoY EPS growth of 17.3% and a track record of beating earnings estimates in 22 of the last 25 quarters. The company’s high operating margin (40.75%) and gross margin (66.92%) reflect pricing power and cost discipline in a defensive sector, while its forward P/E of 21.59 appears justified given growth and stability. Analysts concur with a unanimous buy rating and a $185.75 target price, implying ~19.5% upside, reinforcing confidence in continued outperformance.